Testing: Some Numbers Aren't Worth Their Price Yet
Measurement literacy, not testing ideology — why the trial's numbers meant something a personal two-draw can't rent, and where testing actually pays: the GP's panels with real ranges.
At a glance
- Testing exists: specialist blood panels — real as research tools
- The consumer caveats: no feel-level reference ranges · method/handling variance · no UK pathway on 'low-ish'
- Before/after temptation: two consumer draws can move for non-capsule reasons — and miss real movement
- The replacement: inputs, the evidence-shaped protocol, the 12-week review, GP for symptoms
What the tests are — and the gap between lab and dashboard
The honest inventory first: glutathione testing is real laboratory practice — whole-blood and red-cell GSH assays, sometimes the GSH:GSSG ratio (that ratio's research role) — offered in the UK through specialist and functional-medicine labs at meaningful prices, and genuinely useful in research settings where standardised methods, repeated measures and cohort statistics turn fragile numbers into findings. The consumer gap is everything that doesn't survive the trip from lab to dashboard: no established reference ranges tie an individual's level to how they feel or what they should do (a '15% below optimal' flag has no validated meaning); the analyte itself is fragile — glutathione oxidises quickly after draw, making results sensitive to handling and method in ways that swamp small true differences; and no UK clinical pathway exists that acts on a modestly-low number in a healthy adult — your GP has no protocol for it because medicine hasn't established one (the same honesty on the symptoms side).
The before/after temptation — why the experiment disappoints
The most sympathetic version of this search — test, supplement, retest, know — deserves the most careful letdown: a two-point consumer experiment inherits every fragility above at once, so the after-number can move for reasons that aren't your capsule (different handling, normal biological fluctuation, assay variance) and can sit still while real repletion happens beneath the noise floor — an uninterpretable result at £100-200 that mostly funds a conclusion you'll have to hold loosely anyway. The contrast that explains it: the foundational trial's numbers meant something because of everything around them — standardised assays, multiple blood compartments, six months of scheduled draws, and cohort statistics averaging individual noise into signal (that finding, the endpoint lesson generalised) — rigour a personal two-draw can't rent. This isn't testing scepticism as ideology; it's measurement literacy: some numbers are worth their price, and this one isn't yet.
Futuro Labs Glutathione
£22.99 for 30-day supply · 77p per day
Pros
- 500mg reduced glutathione (GSH) per serving — the active form
- UK manufactured under GMP certification
- Single-ingredient, vegan, no fillers
- Independently lab tested — microbiology and heavy metals
- ~77p per day vs £1.20-1.80/day for liposomal formats
Cons
- Capsule format — no liposomal delivery system
- Newer brand versus heritage names like Solgar
Available from: Amazon UK — £22.99
The replacement protocol — better information, mostly free
What this cluster offers instead of the panel, ranked by information value per pound: act on inputs — smoking, heavy alcohol, sleep debt and protein sufficiency move the system more than any capsule and need no baseline number to justify action (the hierarchy, the alcohol file); run supplementation as the evidence shapes it — Futuro Labs Glutathione at 500mg reduced GSH daily on the 3-6 month clock, quiet expected, the pattern itself being the only compliance metric that matters (£22.99/30 days, ~77p, single-ingredient and independently tested — the record, the timeline); use the 12-week procedural review as your checkpoint — the consistency audit and reason-check that replace the felt milestone and the lab printout alike (the review); and route persistent symptoms where numbers have meaning — the GP's standard panels (thyroid, iron, B12 and kin) carry actual reference ranges and actual pathways, which is what testing is for (that routing). Gates as ever — pregnancy/breastfeeding → medical advice; medication → pharmacist minute — and the close: measure what medicine can act on, review what it can't, and let the £150 stay in your pocket where it's still worth £150.
Frequently asked questions
Can you test your glutathione levels?
Technically yes, usefully rarely: specialist labs offer blood glutathione panels (whole blood, red-cell, sometimes GSH:GSSG ratio), but the consumer-relevant caveats stack high — no established reference ranges tie levels to how you feel or should act, results vary meaningfully by method and sample handling (glutathione oxidises quickly after draw), and no UK clinical pathway acts on a 'low-ish' number in a healthy adult. Research tool: real. Consumer dashboard: not yet, honestly.
Should I test before and after supplementing?
The appeal is obvious and the practice disappoints: between method variance, sample-handling sensitivity and normal biological fluctuation, a two-point before/after on a consumer panel can move for reasons that aren't your capsule — and can miss movement that's real. The foundational trial's rigour (standardised assays, multiple measures, six months, cohort statistics) is what made its numbers meaningful; a £150 two-draw experiment isn't that.
What should I do instead of testing?
The unglamorous protocol this cluster keeps arriving at: act on inputs (smoking, alcohol, sleep, protein — modifiable regardless of any number), run any supplementation as the evidence describes it (daily, 3-6 months, quiet expected), use the 12-week procedural review as your checkpoint — and take persistent symptoms to a GP for panels with actual reference ranges and actual pathways.